Advantage：
1. The high content of enrofloxacin in this product can reduce medication costs and improve breeding efficiency.
2. A weakly acidic formula with a pH value of 5.0-6.0, almost non irritating to animal bodies, strong affinity to tissues, low injection irritation, and more conducive to absorption.
3. Adopting a new type of controlled release technology, combined with rapid release and sustained release, the therapeutic effect is definite.
4. It has a wide antibacterial spectrum and significant inhibitory effects on Escherichia coli, Salmonella, and Mycoplasma.
Prevention and treatment of cellular diseases：
1. Bacterial respiratory disease
Infectious pleuropneumonia, Haemophilus parasuis, porcine pulmonary disease, streptococci, parasuis and other diseases;
2. Digestive tract diseases
Escherichia coli disease (piglet yellow and white dysentery, edema disease), Salmonella disease, swine dysentery Treponema, Leptospira.
3. Urogenital system
Urinary tract inflammation, cystitis, sow mastitis uterine inflammation, and lactation free syndrome (sow triad);
4. Skin diseases
Porcine exudative dermatitis, necrotic bacteria, and Eperythrozoon;
5. Bacterial infections secondary to viral diseases
Such as parasine, streptococcal disease, eperythrozoosis, etc;
6. Various mycoplasma diseases
Swine asthma, porcine synovial mycoplasma infection, and nasal mycoplasma infection.
